Arizona State Retirement System Trims Holdings in Enhabit, Inc. (NYSE:EHAB)

Arizona State Retirement System trimmed its stake in shares of Enhabit, Inc. (NYSE:EHABFree Report) by 12.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,906 shares of the company’s stock after selling 1,645 shares during the quarter. Arizona State Retirement System’s holdings in Enhabit were worth $123,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. SG Americas Securities LLC increased its stake in Enhabit by 258.5% in the third quarter. SG Americas Securities LLC now owns 41,438 shares of the company’s stock valued at $466,000 after acquiring an additional 29,880 shares during the last quarter. Everence Capital Management Inc. bought a new position in shares of Enhabit during the 3rd quarter valued at about $202,000. Exchange Traded Concepts LLC purchased a new position in shares of Enhabit during the 3rd quarter valued at about $1,111,000. Shikiar Asset Management Inc. lifted its position in Enhabit by 90.2% in the 3rd quarter. Shikiar Asset Management Inc. now owns 54,600 shares of the company’s stock worth $614,000 after buying an additional 25,900 shares during the last quarter. Finally, Orion Portfolio Solutions LLC boosted its stake in Enhabit by 5.3% in the third quarter. Orion Portfolio Solutions LLC now owns 75,608 shares of the company’s stock worth $851,000 after buying an additional 3,795 shares in the last quarter.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. UBS Group upgraded shares of Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 price objective for the company in a report on Thursday, March 7th. Oppenheimer reaffirmed a “market perform” rating on shares of Enhabit in a research note on Thursday, March 7th. Finally, Jefferies Financial Group decreased their price objective on Enhabit from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, March 6th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $12.08.

View Our Latest Analysis on Enhabit

Enhabit Price Performance

Shares of Enhabit stock opened at $10.26 on Tuesday. The company’s fifty day simple moving average is $10.20 and its two-hundred day simple moving average is $9.87. Enhabit, Inc. has a 12-month low of $7.12 and a 12-month high of $14.59. The firm has a market cap of $514.60 million, a PE ratio of -6.33, a price-to-earnings-growth ratio of 1.57 and a beta of 1.96. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.76.

Enhabit (NYSE:EHABGet Free Report) last posted its earnings results on Wednesday, March 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.01. The company had revenue of $260.60 million for the quarter, compared to analysts’ expectations of $260.30 million. Enhabit had a positive return on equity of 1.55% and a negative net margin of 7.69%. During the same period last year, the firm earned $0.32 earnings per share. As a group, equities analysts expect that Enhabit, Inc. will post 0.24 EPS for the current year.

Enhabit Profile

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Featured Stories

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.